The report “Cancer Diagnostics
Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray,
Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), by Application
(Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020”, analyzes
and studies the major market drivers, restraints, and opportunities.
Browse 89 market data tables and 37 figures spread through 197 pages and in-depth TOC on “Cancer Diagnostics Market"
will receive 10% customization on this report.
This report studies the global cancer diagnostics market for
the forecast period of 2015 to 2020. This market is expected to reach $13.1
Billion by 2020 from $7.1 Billion in 2015, and is poised to grow at a CAGR of
12.9% during the forecast period.
The global cancer diagnostics market is segmented on the
basis of technology, application, and region. Based on technology, the cancer
diagnostics market is categorized into platform-based and instrument-based. The
instrument-based segment is expected to account for a major share of the cancer
diagnostics market, by product, in 2015.
Inquiry before Buying:
Based on the application, the cancer diagnostics market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma, and others. Breast cancer application is expected to account for a major share of the cancer diagnostics market, by application in 2015.
On the basis of region, the market is divided into North America, Europe, Asia, and Rest of the World (RoW). Rest of the World comprises Latin America, Pacific countries, and Middle East and Africa. North America is expected to account for the largest share in the cancer diagnostics market, followed by Europe and Asia. However, the Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies operating in the cancer diagnostics market.
You can speak To Research Analyst to know more about Report:
The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms. Moreover, the market has seen the advent of hybrid imaging instruments with enhanced accuracy, such as PET/CT and SPECT/CT. These advancements have augmented the growth of the cancer diagnostics market. However, shortage of trained and skilled personnel poses as a restraint to the market growth of cancer diagnostics. Rise in aging population and increasing cancer cases are likely to create huge opportunity for cancer diagnostics.
Some of the major players in the global cancer diagnostics
system market include Agilent Technologies, Inc. (U.S.), Thermo Fisher
Scientific, Inc. (U.S.), Illumina, Inc. (Denmark), Becton, Dickinson and
Company (U.S.), GE Healthcare (U.K.),
QIAGEN N.V. (Netherlands), Abbott
Laboratories, Inc. (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare
(Germany), Philips Healthcare (U.K.), and C.R. Bard, Inc. (U.S.), among others.
Browse Related Reports:
Companion Diagnostics Market by Technology (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry), Application (Breast, Lung cancer), & by End-user (Pharmaceutical Companies, Reference Lab)] - Global Trends & Forecasts to 2019.
Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018.
is the world’s No. 2 firm in terms of annually published premium market
research reports. Serving 1700 global fortune enterprises with more than 1200
premium studies in a year, M&M is catering to a multitude of clients across
8 different industrial verticals. We specialize in consulting assignments and
business research across high growth markets, cutting edge technologies and
newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write
"Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
flagship competitive intelligence and market research platform, "RT"
connects over 200,000 markets and entire value chains for deeper understanding
of the unmet insights along with market sizing and forecasts of niche markets.
The new included chapters on Methodology and Benchmarking presented with high
quality analytical infographics in our reports gives complete visibility of how
the numbers have been arrived and defend the accuracy of the numbers.
MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.
Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets